Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
MedPage Today/Dermatology World Weekly highlighted a Journal of Drugs in Dermatology study comparing a topical JAK inhibitor with a common topical steroid in atopic dermatitis (AD). The study, “Ruxolitinib Cream…
Remember when PASI 75 was the gold medal? Today, it barely makes the podium. In this episode of the JDD Podcast, host Dr. Adam Friedman welcomes Dr. James Song for…
New JDD Data Explore PLLA-SCA for Posterior Thigh Cellulite Have you read this article from the JDD? A new 12 month study is drawing attention for practicing dermatologists and dermatology…
Enhancing Cultural Competency and Clinical Excellence for LGBTQ+ Patients in Dermatology Have you caught up on the latest groundbreaking clinical insights from the Journal of Drugs in Dermatology? The newly…
How CeraVe and Vichy Dercos Are Changing the Way Dermatologists Approach Dandruff Dandruff affects an estimated half of the world's population at some point in their lives, yet traditional treatments…
Integrating science-backed, non-prescription active ingredients into your clinical algorithms Pharmaceuticals and procedures are the backbone of acne treatment, but over-the-counter (OTC) skincare is playing an increasingly critical role. To bridge…